Top Clinical Trials companies in Italy by EBT Margin

This ranking features the top 2 Clinical Trials companies in Italy ranked by EBT Margin, averaging a EBT Margin of -102.80%, for February 08, 2025.

Italy

Clinical Trials
EBT Margin
#
Name
EBT Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
PHIL.MI

Philogen S.p.A.

1

PHIL.MI
-26.72%
Dec. 31, 2023 USD 19.11 -0.17%

Italy
2
NP5.DE

Newron Pharmaceuticals S.p.A.

2

NP5.DE
-178.87%
Dec. 31, 2023 USD 10.99 1.17%

Italy
Frequently Asked Questions
  • Which Clinical Trials company in Italy has the highest EBT Margin ?

    The Clinical Trials company in Italy with the highest EBT Margin is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at -26.72%.

  • Which Clinical Trials company in Italy has the lowest EBT Margin ?

    The Clinical Trials company in Italy with the lowest EBT Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -178.87%.

SV Wall Street